Legacy Investment Solutions, LLC Fate Therapeutics Inc Transaction History

Legacy Investment Solutions, LLC

  • $142 Million
  • Q3 2024

A detailed history of Legacy Investment Solutions, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Legacy Investment Solutions, LLC holds 115 shares of FATE stock, worth $216. This represents 0.0% of its overall portfolio holdings.

Number of Shares
115
Holding current value
$216
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.12 - $5.57 $358 - $640
115 New
115 $0

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $182M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Legacy Investment Solutions, LLC Portfolio

Follow Legacy Investment Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Investment Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Investment Solutions, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email